IASIOS global expansion: First US centre accredited!

November 29, 2023

IASIOS, the International Accreditation System for Interventional Oncology Services, is the first and only accreditation programme for interventional oncology practices. Amidst the ever-evolving field of interventional oncology, IASIOS stands tall with a commitment to fostering high standards based on quality assurance and a global community of world-renowned interventional oncologists.

IASIOS is thrilled to announce that the Mallinckrodt Institute of Radiology at Washington University has achieved the distinction of being an IASIOS Accredited Centre. This accomplishment is more than just an institutional success; it is a major milestone for both IASIOS and the global interventional oncology community. It marks a pioneering step toward setting worldwide standards for interventional oncology, which, in turn, makes safe and effective minimally invasive IO procedures more accessible to patients. We are eager to share some insights from Dr. Jack Jennings, who will shed light on the significant benefits that IASIOS accreditation brings to his institution. The addition of such a respected institution to our ranks is a testament to the collective commitment to raising the bar in interventional oncology practices worldwide, and we look forward to witnessing the positive changes it will bring.

Dr. Jennings (second from left) and his team.

The Mallinckrodt Institute of Radiology at Washington University is the first IASIOS accredited centre in the United States. 

IASIOS: Why did you decide to apply for the IASIOS accreditation?

Jennings: We were aware of the more than 30 institutions in Europe that are members of IASIOS and have heard testimonials about the added quality and safety value they have already received from going through the IASIOS accreditation. Likewise, with the large amount of interventional oncology (IO) that is being done at WashU, we felt our quality and safety programme would greatly benefit. Beyond being a distinguished accreditation, IASIOS is also about membership and community. I knew other members in the IASIOS community and wanted to belong.

IASIOS: How has IASIOS helped improve your IO service line?

Jennings: IASIOS raises the bar for our institution, allowing us to deliver the highest quality and most up-to-date IO procedures, thus optimizing the outcomes for our patients.‌ The application was extensive, comprehensive and thoughtful, while the accreditation criteria align seamlessly with the expectations of high-level performance and quality in the field of interventional oncology.

IASIOS: What benefits does the IO community derive from the IASIOS accreditation?

Jennings: IASIOS elevates our standing to align closely with other institutions performing IO procedures. As the field of interventional oncology continues to expand, this opens up opportunities for us to collaborate and exchange ideas with other institutions doing the same work.

We benefit from this accreditation by being linked to other high-level IO institutions. We are the first US institution to become associated with this esteemed accreditation and hope to lead the way for other IO practices in the US!